Endovascular treatment of resistant and uncontrolled hypertension: Therapies on the horizon

JACC: Cardiovascular Interventions

Volumn 6, Issue 1, 2013, Pages 1-9

  Bunte, Matthew C ^a   Infante De Oliveira, Eduardo ^b   Shishehbor, Mehdi H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

endovascular treatment; renal sympathetic denervation; resistant hypertension

Indexed keywords

BLOOD PRESSURE REGULATION; CATHETER; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); ELECTRODE; ENDOVASCULAR RADIOFREQUENCY RENAL SYMPATHETIC DENERVATION; ENDOVASCULAR SURGERY; HUMAN; INTRAVASCULAR ULTRASOUND SYSTEM; INVASIVE PROCEDURE; KIDNEY DENERVATION; KIDNEY NERVE; NERVE SURGERY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRACTICE GUIDELINE; PRESSORECEPTOR; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RESISTANT HYPERTENSION; REVIEW; SEDATION; SPLANCHNIC NERVE; THORACOLUMBAR SPLANCHNICECTOMY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CATHETER ABLATION; CATHETERS; DRUG RESISTANCE; ENDOVASCULAR PROCEDURES; EQUIPMENT DESIGN; HUMANS; HYPERTENSION; KIDNEY; SYMPATHECTOMY; TREATMENT FAILURE; ULTRASONIC THERAPY;

EID: 84872804200     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.09.005     Document Type: Review

References (31)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. S.C. Bertog, P.A. Sobotka, H. Sievert Renal denervation for hypertension J Am Coll Cardiol Intv 5 2012 249 258
3. D.A. Calhoun, D. Jones, S. Textor Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation 117 2008 e510 e526
4. S.D. Persell Prevalence of resistant hypertension in the United States, 2003-2008 Hypertension 57 2011 1076 1080
5. A.V. Chobanian Shattuck lecture: the hypertension paradox - more uncontrolled disease despite improved therapy N Engl J Med 361 2009 878 887
6. B.M. Egan, Y. Zhao, R.N. Axon, W.A. Brzezinski, K.C. Ferdinand Uncontrolled and apparent treatment resistant hypertension in the United States, 1988-2008 Circulation 124 2011 1046 1058
7. K.M. Flegal, M.D. Carroll, C.L. Ogden, L.R. Curtin Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 2010 235 241
8. E.V. Allen Symposium on the treatment of essential hypertension; introduction Proc Staff Meet Mayo Clinic 27 1952 473 474
9. R.H. Smithwick, J.E. Thompson Splanchnicectomy for essential hypertension; results in 1,266 cases JAMA 152 1953 1501 1504
10. R.E. Katholi Renal nerves in the pathogenesis of hypertension in experimental animals and humans Am J Physiol 245 1983 F1 F14
11. M. Esler The 2009 Carl Ludwig lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management J Appl Physiol 108 2010 227 237
12. D. Prochnau, N. Lucas, H. Kuehnert, H.R. Figulla, R. Surber Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter EuroIntervention 7 2012 1077 1080
13. H. Krum, M. Schlaich, R. Whitbourn Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Lancet 373 2009 1275 1281
14. M.D. Esler, H. Krum, P.A. Sobotka SYMPLICITY HTN-2 Investigators Renal sympathetic denervation in patients with treatment-resistant hypertension (The SYMPLICITY HTN-2 trial): a randomised controlled trial Lancet 376 2010 1903 1909
15. M. Doumas, S. Douma Interventional management of resistant hypertension Lancet 373 2009 1228 1230
16. G. Grassi, F. Quarti-Trevano, G. Brambilla, G. Seravalle Blood pressure control in resistant hypertension: new therapeutic options Expert Rev Cardiovasc Ther 8 2010 1579 1585
17. R.E. Katholi, K.J. Rocha-Singh, N.J. Goswami, P.A. Sobotka Renal nerves in the maintenance of hypertension: a potential therapeutic target Curr Hypertens Rep 12 2010 196 204
18. M.P. Schlaich, H. Krum, P.A. Sobotka Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension Curr Hypertens Rep 12 2010 39 46
19. Medtronic, Inc. "Symplicity Catheter [Instructions for use]." www.medtronicrdn.com 2010 Accessed July 17, 2012
20. SYMPLICITY HTN-1 Investigators Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months Hypertension 57 2011 911 917
21. The SYMPLICITY HTN-1 Investigators. Three-year follow-up of SYMPLICITY HTN-1 trial. Abstract presented at the 61st Annual Scientific Sessions of the American College of Cardiology. March 25, 2012; Chicago, IL.
22. Worthley S. Safety and efficacy of a novel quadrapolar renal denervation catheter in patients with resistant hypertension: a first-in-man multicenter study. Abstract presented at the 2012 Annual Scientific Sessions of the European Association for Percutaneous Cardiovascular Interventions. May 16, 2012; Paris, France.
23. Hoppe U. Clinical experience with Vessix Vascular balloon renal denervation catheter. Abstract presented at the 2012 Annual Scientific Sessions of the European Association for Percutaneous Cardiovascular Interventions. May 17, 2012; Paris, France.
24. H. Ahmed, P. Neuzil, J. Skoda Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension J Am Coll Cardiol Intv 5 2012 758 765
25. Bonan, R. PARADISE: first-in-man results of a novel circumferential catheter-based ultrasound technology for renal denervation. Abstract presented at the 2012 Annual Scientific Sessions of the European Association for Percutaneous Cardiovascular Interventions. May 16, 2012; Paris, France.
26. Y.A. Pan, T. Misgeld, J.W. Lichtman, J.R. Sanes Effects of neurotoxic and neuroprotective agents on peripheral nerve regeneration assayed by time-lapse imaging in vivo J Neurosci 23 2003 11479 11488
27. C. Stefanadis Renal denervation in resistant hypertension: radiofrequency ablation and chemical denervation Hellenic J Cardiol 52 2011 481 482
28. P.T. Manning, C.W. Powers, R.E. Schmidt, E.M. Johnson Jr Guanethidine-induced destruction of peripheral sympathetic neurons occurs by an immune-mediated mechanism J Neurosci 3 1983 714 724
29. K. Wustmann, J.P. Kucera, I. Scheffers Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension Hypertension 54 2009 530 536
30. J.D. Bisognano, G. Bakris, M.K. Nadim Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial J Am Coll Cardiol 58 2011 765 773
31. B.M. Mearns Hypertension: baroreflex activation therapy lowers BP Nat Rev Cardiol 8 2011 540